实用肿瘤学杂志 ›› 2012, Vol. 26 ›› Issue (2): 137-140.doi: 10.3969/j.issn.1002-3070.2012.02.009

• 论著 • 上一篇    下一篇

肿瘤相关抗原HSC70在食管癌中的鉴定与表达研究

高红军1, 岳志刚1, 周艳秋1, 许慧1, 段志玲1, 郑朝旭2   

  1. 1.煤炭总医院检验科(北京 100028);
    2.中国医学科学院肿瘤医院腹部外科
  • 收稿日期:2012-02-01 出版日期:2012-04-28 发布日期:2014-12-03
  • 通讯作者: 郑朝旭,E-mail:zzx-2003@126.com
  • 作者简介:高红军,男,(1977-),博士,副主任临床检验师,从事肿瘤标志物的研究及临床检验工作

The identification and expression study of HSC70 as a candidate of tumor associated antigen in esophageal squamous cell carcinoma

GAO Hongjun1,YUE Zhigang1,ZHOU Yanqiu1,XUHui1,DUAN Zhiling1,ZHENG Zhaoxu2   

  1. 1.Clinical Laboratory of Coal General Hospital,Beijing 100028;
    2.Department of Abdominal Surgery,Cancer Institute & Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100021
  • Received:2012-02-01 Online:2012-04-28 Published:2014-12-03

摘要: 目的 探索食管鳞状细胞癌的肿瘤相关抗原。方法 提取食管鳞状细胞癌组织蛋白,用20例食管癌患者血清和20例健康对照血清分别作为检测抗体进行Western blot分析,比较分析二者的差异,将差异蛋白酶解后用质谱进行鉴定分析;用免疫组化方法对鉴定的肿瘤相关抗原进行验证。结果 食管癌血清的阳性信号比较多,其中70 kDa的蛋白阳性率为40%(8/20),而健康对照血清阳性率为0%(0/20),该蛋白被鉴定为HSC70或称HSPA8。免疫组化结果显示HSC70在食管癌组织主要表达于细胞浆和细胞核,且表达明显高于癌旁正常组织。结论 联合免疫印记和质谱技术可以鉴定肿瘤相关抗原;HSC70可能是食管癌发生的重要参与蛋白,可能是食管癌诊断和治疗的关键靶分子。

Abstract: Objective To identify novel tumor associated antigens(TAA)in esophageal squamous cell carcinoma(ESCC).Methods The proteins extracted from tissues of ESCC were separated by two dimensional polyacrylamide gel electrophoresis,and followed by Western blot analysis in which sera from 20 patients with ESCC and 20 healthy controls were tested for primary antibodies.Positive spots were excised from Coomassie blue-stained gels and the tryptic peptides were analyzed by matrix-assisted laser disorption/ionization time-of-flight mass spectrometry(MALDI-TOF-MS).The expression of the candidate TAA in ESCC tissue was detected by immunohistochemical staining(IHC).Results Sera from patients with ESCC yielded multiple spots,one of which was identified as heat shock 70kDa protein 8(HSC70 or HSPA8)by MALDI-TOF-MS.The immunohistochemistry analysis showed that HSC70 was located in both cytoplasm and nucleus,and had a higher expression in cancer tissues than paracarcinoma normal tissue.Conclusion The combination of immunoblot and mass spectrometry may identify some novel TAAs.These results suggested that HSC70 may play a role in tumorigenesis of ESCC,and may be a key diagnostic and therapeutic target.

中图分类号: